Digital Balancing global consistency and local nuance: EVERSANA on A... The conversation around global brand launches is evolving rapidly – and EVERSANA and its agency team at EVERSANA INTOUCH’s leadership is at the centre
Market Access Why impactful and scalable global Medical Information (MI) p... A trusted MI partner ensures compliance with global and local regulations and provides consistent access to accurate medical information.
Sales & Marketing Optimising customer experience in global medical information... Technology and AI may come to bear in establishing global MI services.
Sales & Marketing Optimising customer experience in global medical information... In MI, it is increasingly important to find methodologies to increase global efficiencies while optimising the customer experience.
Market Access Part Two: Navigating the complexities of global market acces... The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world.
Market Access Part One: Overcoming challenges and seizing opportunities in... The outlook for drug development to treat rare diseases looks encouraging, offering hope to the 300 million people globally facing the significant challenges of these often-overlooked condi
Digital On AI and computational support of biochemistry, with Alan R... Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.